Scientific Articles

An open-label study of pemigatinib in cholangiocarcinoma: final results from FIGHT-202

 

A Vogel, V Sahai, A Hollebecque, G M Vaccaro, D Melisi, R M Al Rajabi, A S Paulson, M J Borad, D Gallinson, A G Murphy, D-Y Oh, E Dotan, D V Catenacci, E Van Cutsem, C F Lihou, H Zhen, M L Veronese, G K Abou-Alfa

ESMO Open, 2024 Jun. 9

Abstract Link

 

 

 

 

 

 

 

Copyright © 2024 The Author(s). Published by Elsevier Ltd.. All rights reserved.